CELG-RI
Bristol-Myers Squibb Company Ce
NYSE · Healthcare · Drug Manufacturers - General · US
$0.14
−6.69%Margins
Gross margin
67.0%
EBITDA margin
38.1%
EBIT margin
31.7%
Net margin
15.0%
FCF margin
24.6%
36.3%
Return on equity
8.4%
Return on assets
23.1%
Return on invested capital
0.55x
Asset turnover
$13.3B
Cash from operations
$5.16
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026